Delivery Order SPE2DB25D3017-SPE2DB25FVJYR
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 26, 2025, for Norditropin FlexPro 15 mg/1.5 mL pharmaceutical products, with a ceiling value of $2,202.89. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by June 27, 2025. The delivery order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This award represents a child delivery order under...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $5,917.35 to AmerisourceBergen Drug Corp for Norditropin FlexPro 10 mg/1.5 mL, a human growth hormone therapeutic product. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by August 25, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, served as the prime contractor for this pharmaceutical supply delivery. This...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Norditropin FlexPro 15 mg/1.5 mL, a human growth hormone medication. This firm fixed-price delivery order, valued at $2,208.18, is set to be completed by November 10, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a non-competitive delivery against AmerisourceBergen's existing indefinite delivery contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Norditropin FlexPro 15 mg/1.5 mL, a human growth hormone medication. The contract, valued at $2,208.18, represents a firm fixed price delivery order with an ultimate completion date of November 4, 2025. This award was issued without set-aside designation, indicating competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Norditropin FlexPro 15 mg/1.5 mL, a human growth hormone medication. This firm fixed-price delivery order, valued at $6,984.60, is scheduled for completion by September 16, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was competitively granted with no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a delivery order valued at $1,049.60 to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Norditropin FlexPro 10 mg/1.5 mL, a human growth hormone medication. This non-set-aside, firm fixed-price delivery order is scheduled for completion by November 14, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement through the Defense...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Norditropin FlexPro 10 mg/1.5 mL, a human growth hormone medication, with a ceiling value of $3,435.04. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by October 31, 2025. The order will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Norditropin Flexpro 10 mg/1.5 mL, a human growth hormone medication, with a ceiling value of $1,590.66. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is classified as a delivery order under the company's larger pharmaceutical supply agreement with DLA. The place of performance is AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,021.04 to AmerisourceBergen Drug Corp for Norditropin FlexPro 10 mg/1.5 mL, a human growth hormone treatment. The contract was competitively awarded on December 10, 2025, with a firm fixed price structure and an ultimate completion date of December 11, 2025. Performance will be fulfilled at the awardee's location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's broader...
- The Defense Logistics Agency (DLA) awarded a $3,852.66 delivery order to AmerisourceBergen Drug Corp for Norditropin Flexpro 10 mg/1.5 ml pharmaceutical products, with completion targeted for November 4, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The contract carries no set-aside designation and will be performed at the contractor's corporate...
- SPE2DB25D3017Indefinite Delivery Contract
- SPE2DB25D3017-SPE2DB25FVJYRDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Norditropin Flexpro 10 mg/1.5 ml injections with a contract value of $1,862.48. This firm fixed price delivery order represents a non-competitive set-aside and is scheduled for completion by July 24, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026 that enables the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical procurement vendor for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company maintains an extensive portfolio of federal contract awards through the DLA Medical Supply Chain, supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This delivery order for growth hormone treatment aligns with AmerisourceBergen's demonstrated capability to meet federal procurement requirements through competitive processes and supports the military's ongoing pharmaceutical supply needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 7/23/25 |